Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1959 1
1963 3
1967 1
1970 6
1971 1
1972 2
1973 3
1974 1
1975 3
1976 6
1977 4
1978 2
1979 4
1980 3
1981 6
1982 1
1983 9
1984 8
1985 9
1986 5
1987 16
1988 11
1989 8
1990 10
1991 13
1992 16
1993 14
1994 7
1995 10
1996 7
1997 14
1998 8
1999 13
2000 21
2001 10
2002 15
2003 22
2004 12
2005 22
2006 16
2007 11
2008 19
2009 11
2010 11
2011 13
2012 13
2013 18
2014 15
2015 22
2016 31
2017 27
2018 30
2019 54
2020 41
2021 67
2022 24
Text availability
Article attribute
Article type
Publication date

Search Results

691 results
Results by year
Filters applied: . Clear all
Page 1
Cutaneous B-Cell Lymphoma.
Goyal A, LeBlanc RE, Carter JB. Goyal A, et al. Among authors: leblanc re. Hematol Oncol Clin North Am. 2019 Feb;33(1):149-161. doi: 10.1016/j.hoc.2018.08.006. Hematol Oncol Clin North Am. 2019. PMID: 30497672 Review.
Crossing the blood-brain barrier with nanoparticles.
Zhou Y, Peng Z, Seven ES, Leblanc RM. Zhou Y, et al. Among authors: leblanc rm. J Control Release. 2018 Jan 28;270:290-303. doi: 10.1016/j.jconrel.2017.12.015. Epub 2017 Dec 19. J Control Release. 2018. PMID: 29269142 Review.
Elotuzumab plus Pomalidomide and Dexamethasone for Multiple Myeloma.
Dimopoulos MA, Dytfeld D, Grosicki S, Moreau P, Takezako N, Hori M, Leleu X, LeBlanc R, Suzuki K, Raab MS, Richardson PG, Popa McKiver M, Jou YM, Shelat SG, Robbins M, Rafferty B, San-Miguel J. Dimopoulos MA, et al. Among authors: leblanc r. N Engl J Med. 2018 Nov 8;379(19):1811-1822. doi: 10.1056/NEJMoa1805762. N Engl J Med. 2018. PMID: 30403938 Clinical Trial.
Tetraspanin-6 negatively regulates exosome production.
Ghossoub R, Chéry M, Audebert S, Leblanc R, Egea-Jimenez AL, Lembo F, Mammar S, Le Dez F, Camoin L, Borg JP, Rubinstein E, David G, Zimmermann P. Ghossoub R, et al. Among authors: leblanc r. Proc Natl Acad Sci U S A. 2020 Mar 17;117(11):5913-5922. doi: 10.1073/pnas.1922447117. Epub 2020 Feb 27. Proc Natl Acad Sci U S A. 2020. PMID: 32108028 Free PMC article.
Nanoparticle-mediated targeted drug delivery for breast cancer treatment.
Liyanage PY, Hettiarachchi SD, Zhou Y, Ouhtit A, Seven ES, Oztan CY, Celik E, Leblanc RM. Liyanage PY, et al. Among authors: leblanc rm. Biochim Biophys Acta Rev Cancer. 2019 Apr;1871(2):419-433. doi: 10.1016/j.bbcan.2019.04.006. Epub 2019 Apr 26. Biochim Biophys Acta Rev Cancer. 2019. PMID: 31034927 Free PMC article. Review.
Clinicopathologic predictors of renal outcomes in light chain cast nephropathy: a multicenter retrospective study.
Royal V, Leung N, Troyanov S, Nasr SH, Écotière L, LeBlanc R, Adam BA, Angioi A, Alexander MP, Asunis AM, Barreca A, Bianco P, Cohen C, Drosou ME, Fatima H, Fenoglio R, Gougeon F, Goujon JM, Herrera GA, Knebelmann B, Lepori N, Maletta F, Manso R, Motwani SS, Pani A, Rabant M, Rennke HG, Rocatello D, Rosenblum F, Sanders PW, Santos A, Soto K, Sis B, Touchard G, Venner CP, Bridoux F. Royal V, et al. Among authors: leblanc r. Blood. 2020 May 21;135(21):1833-1846. doi: 10.1182/blood.2019003807. Blood. 2020. PMID: 32160635 Free PMC article.
Isatuximab plus carfilzomib and dexamethasone versus carfilzomib and dexamethasone in relapsed multiple myeloma patients with renal impairment: IKEMA subgroup analysis.
Capra M, Martin T, Moreau P, Baker R, Pour L, Min CK, Leleu X, Mohty M, Segura MR, Turgut M, LeBlanc R, Risse ML, Malinge L, Schwab S, Dimopoulos M. Capra M, et al. Among authors: leblanc r. Haematologica. 2021 Oct 14. doi: 10.3324/haematol.2021.279229. Online ahead of print. Haematologica. 2021. PMID: 34647444 Free article.
Daratumumab monotherapy in patients with treatment-refractory multiple myeloma (SIRIUS): an open-label, randomised, phase 2 trial.
Lonial S, Weiss BM, Usmani SZ, Singhal S, Chari A, Bahlis NJ, Belch A, Krishnan A, Vescio RA, Mateos MV, Mazumder A, Orlowski RZ, Sutherland HJ, Bladé J, Scott EC, Oriol A, Berdeja J, Gharibo M, Stevens DA, LeBlanc R, Sebag M, Callander N, Jakubowiak A, White D, de la Rubia J, Richardson PG, Lisby S, Feng H, Uhlar CM, Khan I, Ahmadi T, Voorhees PM. Lonial S, et al. Among authors: leblanc r. Lancet. 2016 Apr 9;387(10027):1551-1560. doi: 10.1016/S0140-6736(15)01120-4. Epub 2016 Jan 7. Lancet. 2016. PMID: 26778538 Clinical Trial.
Weekly carfilzomib plus cyclophosphamide and dexamethasone in the treatment of relapsed/refractory multiple myeloma: Final results from the MCRN-003/MYX.1 single arm phase II trial.
Venner CP, LeBlanc R, Sandhu I, White D, Belch AR, Reece DE, Chen C, Dolan S, Lalancette M, Louzada M, Kew A, McCurdy A, Monteith B, Reiman T, McDonald G, Sherry M, Gul E, Chen BE, Hay AE. Venner CP, et al. Among authors: leblanc r. Am J Hematol. 2021 May 1;96(5):552-560. doi: 10.1002/ajh.26147. Am J Hematol. 2021. PMID: 33650179 Free article. Clinical Trial.
691 results